Is NAMS stock a Buy, Sell, or Hold?

Based on our analysis, NAMS is currently a HOLD with moderate confidence. 📊 HOLD: NAMS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

What is the fair value of NAMS stock?

Our analysis estimates the fair value range for NAMS to be between $30.33 and $35.18. The current price is $31.40.

What is the analyst price target for NAMS?

The average Wall Street analyst price target for NAMS is $49.30. This implies a potential upside of 57.0% from current levels.

NAMS Stock Analysis: Buy, Sell, or Hold?

NAMS - NewAmsterdam Pharma Company N.V. Ordinary Shares

PHARMACEUTICAL PREPARATIONS

$31.40

0.58 (1.88%) ▲

5d: +2.61%

30d: -12.14%

90d: +4.63%

HOLD

MODERATE Confidence

Protect Your NAMS Gains

Analysis Updated: Jun 23, 2026 12:00 AM ET

Earnings: Aug 05, 2026

Get Alerted When NAMS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: NAMS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: NAMS is currently trading at $31.40, which is considered slightly low relative to its 30-day fair value range of $30.33 to $35.18.

Technical Outlook: Technically, NAMS is showing sideways momentum. The price is approaching resistance at $32.04. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: NAMS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $49.30 (+57.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW

Historical Trading Range $30.33 - $35.18

Company Quality Score 50/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 57.9%

Protect Your Profits

Holding NAMS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Trading 57.0% below Wall St target ($49.30)

Trading Range Analysis

30-Day Trading Range $30.33 - $35.18

Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $29.10

Resistance Level $32.04

Current Trend Sideways

Technical data as of Jun 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) -23.80

Wall Street Target $49.30 (+57.0%)

Revenue Growth (YoY) 2.1%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: June 23, 2026 6:26 PM ET
Data refreshes hourly during market hours. Next update: 7:26 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is NAMS showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Louis G Lange SELL 44619 shares 2026-03-11

Johannes Jacob Piete Kas… SELL 101409 shares 2026-03-09

Johannes Jacob Piete Kas… SELL 94124 shares 2026-03-06

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for NAMS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
BMRN Biomarin Pharmaceutical …	STRONG BUY 29 analysts	$88	65 BUY
ALNY Alnylam Pharmaceuticals …	STRONG BUY 30 analysts	$436	54 HOLD
VRTX Vertex Pharmaceuticals I…	BUY 34 analysts	$549	67 BUY
CRSP Crispr Therapeutics AG	BUY 28 analysts	$84	59 HOLD
LEGN Legend Biotech Corp	STRONG BUY 22 analysts	$58	52 HOLD

BMRN Biomarin Pharmace…

65 BUY

ALNY Alnylam Pharmaceu…

54 HOLD

VRTX Vertex Pharmaceut…

67 BUY

CRSP Crispr Therapeuti…

59 HOLD

LEGN Legend Biotech Co…

52 HOLD

Advanced NAMS Option Strategies

Professional options setups generated by AI based on today's NAMS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NAMS

NAMS Technical Chart NAMS Price Prediction NAMS Earnings Date NAMS Investment Advisor NAMS Fair Price Analyzer NAMS Options Advisor NAMS Options Chain NAMS Options Analysis NAMS Competitors

Compare NAMS with Peers

NAMS vs MLYS
Which one to buy?

NAMS vs EWTX
Which one to buy?

NAMS vs APGE
Which one to buy?

NAMS vs IRON
Which one to buy?

NAMS vs ELVN
Which one to buy?

GPCR vs NAMS
Winner: GPCR

ALMS vs NAMS

RLAY vs NAMS

INSM vs NAMS
Winner: NAMS

ELVN vs NAMS

TLX vs NAMS

DNLI vs NAMS
Winner: NAMS

ARQT vs NAMS

LVTX vs NAMS

BEAM vs NAMS

Create New Comparison View All Competitors

Tradestie